newsfilter
← Latest News
GlobeNewswire·

Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million

ADELAIDE, Australia, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (NASDAQ:BNOX, ASX: BNO)) (Bionomics or Company), a clinical stage biopharmaceutical company, is pleased to announce that the Company has received